Abstract. The Modification of Diet in Renal Disease (MDRD) Study was the largest randomized
clinical trial to test the hypothesis that protein restriction slows the progression of chronic …

… Although CIT is a powerful risk factor for DGF, it was not an independent risk factor for
early or late graft survival in Hunsicker's multivariate analysis. This suggests that DGF is …

Background It is unknown whether either the angiotensin-II–receptor blocker irbesartan or the
calcium-channel blocker amlodipine slows the progression of nephropathy in patients with …

Background Renal function declines progressively in patients who have diabetic nephropathy,
and the decline may be slowed by antihypertensive drugs. The purpose of this study was …

The Banff 97 working classification of renal allograft pathology. Background Standardization
of renal allograft biopsy interpretation is necessary to guide therapy and to establish an …

Objective: To examine the relations among proteinuria, prescribed and achieved blood
pressure, and decline in glomerular filtration rate in the Modification of Diet in Renal Disease …

… Hunsicker , Jean-Lucien Rouleau , Julia B. Lewis , Clive Rosendorff , Jerome G. Porush ,
Paul L. … EJ Lewis, LG Hunsicker, WR Clarke, et al. …

… DISEASE (MDRD) STUDY GROUP (prepared by BECK GJ, BERG RL, COGGINS CH,
GASSMAN JJ, HUNSICKER LG, SCHLUCHTER MD, WILLIAMS GW): Design and statistical …

We described the characteristics in a referred cohort of type II diabetic patients in the
Developing Education on Microalbuminuria for Awareness of renal and cardiovascular risk in …

OBJECTIVE Impaired awareness of hypoglycemia (IAH) and severe hypoglycemic events (SHEs)
cause substantial morbidity and mortality in patients with type 1 diabetes (T1D). …